What is the 𝐝𝐚𝐫𝐤 𝐩𝐫𝐨𝐭𝐞𝐨𝐦𝐞 & what role does it plays in the manifestation & progression of diseases like #cancer?. See recent findings that reinforce why the #darkproteome is a critical new frontier to explore as part of #drugdevelopment:

We're thrilled to announce the launch of 𝐃𝐲𝐧𝐚𝐦𝐢𝐐™ as our next-generation data insights engine for drug discovery & development!. See all the ways we can use this deeply phenotyped #multiomics database for longitudinal analyses & request a #demo:

Congrats to @pitt_medicine researchers for the publication of their landmark study in 𝘚𝘤𝘪𝘦𝘯𝘤𝘦 which links lysosomal biology & oxysterol metabolism to pulmonary arterial hypertension (#PAH) pathobiology. #Metabolomics data was provided by Sapient!.

We are excited to share that we have partnered with @AlamarBio to extend our targeted #proteomics services using their NULISA™ panels and assays for cytokines, chemokines, and inflammatory mediators. Read the press release for details:

#Whitepaper: Explore the significant technological advancements in protein extraction, mass spectrometry hardware, and data handling software that are rapidly changing the clinical conversation around mass spectrometry.

It's time to rethink #massspectrometry's role in clinical protein assays. This #whitepaper explores advancements in mass spectrometry-based proteomics to now deliver the depth, sensitivity & reproducibility required for clinical protein measures:

We are excited to share a strategic leadership transition for continued acceleration of our growth & scientific impact. Dr. Jonathan Usuka will assume the role of CEO and Dr. Mo Jain will continue as a Sapient Board member & transition to the role of CSO:

Breakthroughs in our collaboration with @BayAreaLyme on the first diagnostic for persistent #Lyme disease are highlighted in the foundation's 2024 Impact Report. See how this #ML multi-biomarker test shows high sensitivity & specificity for diagnosis:

Sapient has partnered with #RanchoBioSciences to accelerate the next generation of our Human Biology Database. See how the collaboration will help to increase the breadth and depth of multidimensional insights we can deliver to inform #drugdevelopment.

Check out this #TechnicalNote which describes Sapient’s nontargeted mass spectrometry #QC workflows and how this comprehensive quality matrix was applied across >40,000 human biological samples for a large population-based study: #QCanalysis #biomarkers

𝐃𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭𝐢𝐚𝐥. 𝐃𝐢𝐬𝐞𝐚𝐬𝐞-𝐦𝐨𝐝𝐢𝐟𝐲𝐢𝐧𝐠. 𝐓𝐫𝐚𝐜𝐭𝐚𝐛𝐥𝐞. Join our live #webinar on 9/18 to learn how you can identify protein targets with these characteristics via mass spectrometry-based #proteomics & #AI-based target validation.

We are proud to have contributed to a groundbreaking study recently published in @NaturePortfolio Metabolism, detailing an innovative approach for assaying metabolic activities in intact human #livertissue. This #pressrelease highlights key findings:

Join this #webinar, hosted @AAPSComms, to hear how mass spectrometry-based discovery #proteomics combined with #AI-based target validation can be used to comprehensively profile the breadth of the #proteome to identify the best target for a given therapy:

Deep dive into the latest advances for gathering, integrating, and interpreting #multiomics data for #biomarker discovery in this new eBook presented by @TheScientistLLC: #metabolomics #lipidomics #proteomics #biomarkers

Developing #ADCs demands an efficient way to comprehensively characterize tumor-associated antigens & the effects of ADC binding to these targets. See how /𝐃𝐞𝐞𝐩/ 𝐂𝐞𝐥𝐥 𝐒𝐮𝐫𝐟𝐚𝐜𝐞 𝐏𝐫𝐨𝐭𝐞𝐨𝐦𝐢𝐜𝐬 can measure these cell surface proteins:

We've made a significant advancement in our #metabolomics & #lipidomics services, expanding our #metabolite identification database to include >10,000 chemical standards and >1,000 ‘Tier 1+’ identifications of metabolites & lipids measured in humans:

Do you have a specific protein of interest or target to modulate? Explore Sapient's interactive 𝐓𝐚𝐫𝐠𝐞𝐭𝐞𝐝 𝐏𝐫𝐨𝐭𝐞𝐢𝐧 𝐀𝐬𝐬𝐚𝐲 𝐌𝐞𝐧𝐮 of >12,000 proteins measured via our mass spectrometry-based platform: #proteinassays #targetedproteomics

#xTech Futures from @Deloitte highlights exponential technologies likely to change the way our world works & lives. We're honored to have had the opportunity to contribute & have Sapient featured in their new xTech Futures: #BioTech report!.

What are two key aspects of #AI required for strong prediction? How is #multiomics data taking pharmacogenomics to the next level?. Our feature on @PharmacyPodcast discusses these timely topics & more. Listen here or on your favorite #podcast platform:

Thank you to @GENbio for profiling Sapient as part of its feature on omics technologies enabling the discovery and implementation of #multiomics #biomarkers in drug development programs today.